|
1st
International Course
INTEGRATED
BIOMARKERS
BIOCHEMICAL AND BIOIMAGING ENDPOINTS
IN CARDIOCEREBROVASCULAR DIAGNOSIS, PREVENTION, THERAPY,
AND DRUG DEVELOPMENT
Lugano
(Switzerland) - October 27-29, 2005
Under
the Auspices of:
European Association of Nuclear Medicine
European Federation for Pharmaceutical Sciences
Fondazione Italiana per il Cuore
International Atherosclerosis Society
International Federation of Clinical Chemistry and
Laboratory Medicine
International Task Force of Prevention of Coronary
Heart Disease
Society of Atherosclerosis Imaging
World Heart Federation |
|
|
|
O.J. Bjerrum
(Denmark) - V. Fuster
(USA) - R. Paoletti
(Italy)
Course
Coordinator: A.P.
Peracino (Italy)
| SCIENTIFIC
PROGRAMME COMMITTEE |
A.L. Catapano
(Italy) - F. Crea
(Italy) - S.M. Marcovina
(USA) - P.L. Pieri
(Italy) - E. Tremoli
(Italy)
| INTERNATIONAL
ADVISORY BOARD |
G. Assmann (Germany)
- P. Bonini
(Italy) - G. Brown
(USA) - A.L. Catapano
(Italy) - R.H. Christenson
(USA) - F. Crea
(Italy) - P. De Feyter
(The Netherlands) - R. Dietz
(Germany) - M. Ferrari
(Italy) - J. Heinecke
(USA) - D. Hochstrasser
(Switzerland) - A. Jacobs
(Germany) - P. Libby
(USA) - S.M. Marcovina (USA)
- A. Maseri
(Italy) - P. Mocarelli
(Italy) - M. Müller
(Austria) - S.E. Nissen
(USA) - D. Orloff
(USA) - M. Panteghini
(Italy) - M.S. Phillips
(Canada) - P.L. Pieri
(Italy) - M. Plebani
(Italy) - P. Raggi
(USA) - P. Ridker
(USA) - G. Steiner
(Canada) - J-C. Tardif
(Canada) - E. Tremoli
(Italy) - A. Von Eckardstein
(Switzerland)
THURSDAY,
OCTOBER 27
|
Opening
Remarks (2.00 p.m.)
Ole
J. Bjerrum (Copenhagen, Denmark)
Valentin Fuster (New York, USA)
Rodolfo Paoletti (Milan, Italy)
|
|
Opening
Lecture
Introduction
to Integrated Biomarkers in Cardiovascular Diagnosis,
Prevention, and Therapy
Valentin Fuster (New York, USA) |
|
Plenary
Sessions
CLINICIANS’
DECISION MAKING IN CARDIOCEREBROVASCULAR DISEASES: open
questions
| Risk
Stratification in Asymptomatic Subjects |
Wolfgang
Koenig (Ulm, Germany) |
| Acute
Coronary Syndrome |
Juan
Carlos Kaski (London, UK) |
| Heart
Failure |
Claudio
Rapezzi (Bologna, Italy) |
| Transient
Ischemic Attack and Stroke |
Jan
Sobesky (Cologne, Germany) |
| Diabetes |
Antonio
Pontiroli (Milan, Italy) |
Purpose
of this session:
To highlight the problems and critical areas in
clinical decision making in five clinical-patho-
logical areas for an individualized diagnosis. |
|
|
Rapporteurs
(throughout the Course)
Rapporteurs
will participate in all the sessions and will collect
critical points, shadow areas, issues for reflection,
and proposals to be discussed in the final session (Saturday,
October 29).
They are experts on biochemical/bioimaging markers and
on clinical decision making:
Santica
M. Marcovina (Seattle, USA)
Filippo Crea (Rome, Italy)
Jean Davignon (Montreal, Canada)
Pier Luigi Pieri (Cesena, Italy)
|
FRIDAY,
OCTOBER 28
|
Workshops
Participants,
divided into two groups, will attend all the Workshops
|
|
BIOCHEMICAL
MARKERS TOWARDS INTEGRATION: methodological criteria
To
define the criteria for the integration of biochemical
markers in terms of:
| Quality
Specifications |
Mauro
Panteghini (Milan, Italy) |
| Clinical
Utility |
Allan
S. Jaffe (Rochester, USA) |
| Health
Economy |
Bengt
Jönsson (Stockholm, Sweden) |
|
| BIOIMAGING
MARKERS TOWARDS INTEGRATION: methodological criteria
To
define the criteria for the integration of bioimaging
markers in terms of:
| Quality
Specifications |
Pasquale
Perrone Filardi (Naples, Italy) |
| Clinical
Utility |
Paolo
Raggi (New Orleans, USA) |
| Health
Economy |
Leslee
Shaw (Los Angeles, USA) |
|
| BIOCHEMICAL
MARKERS TOWARDS INTEGRATION: predictive value
To
define the predictive value of selected biomarkers alone
or in combination in terms of:
| Acute
Coronary Syndrome |
Martin
Möckel (Berlin, Germany) |
| Heart
Failure |
Ulf
Landmesser (Hannover, Germany) |
| Transient
Ischemic Attack and Stroke |
Joan
Montaner (Barcelona, Spain) |
|
| BIOIMAGING
MARKERS TOWARDS INTEGRATION: predictive value
To
define the predictive value of selected biomarkers alone
or in combination in terms of:
| Acute
Coronary Syndrome |
Jeanette
Schulz-Menger (Berlin,
Germany) |
| Heart
Failure |
Mauro
Pepi (Milan,
Italy) |
| Transient
Ischemic Attack and Stroke |
Gian Luigi Lenzi
(Rome, Italy) |
|
SATURDAY,
OCTOBER 29
|
Round
Table
INTEGRATED
BIOCHEMICAL AND BIOIMAGING MARKERS IN CARDIOCEREBROVASCULAR
DISEASES:
answers and proposals for further developments
To
define the pros and cons of the use of integrated biomarkers
in clinical decision making in:
Risk
Stratification in Asymptomatic Subjects
Acute Coronary Syndrome
Heart Failure
Transient Ischemic Attack and Stroke
Diabetes
Discussants:
Rapporteurs and Clinicians
Purpose
of this session:
This session will attempt to answer the questions presented
in the opening plenary session. The rapporteurs will
present a synthesis of the critical points, shadow areas,
issues for reflection, and proposals to be discussed
that emerged during the various Workshops. The rapporteurs
and the clinicians will discuss the pros and cons of
the use of integrated biomarkers in the clinical decision
making process.
|
|
SCIENTIFIC-ORGANIZING SECRETARIATS:
Main
Office
Biomarkers 2005
Fondazione Giovanni Lorenzini
Medical Science Foundation
Via Appiani 7 - 20121 MILAN - ITALY
Phone: + (39) 02 29006267
Fax + (39) 02 29007018
E-mail:
biomarkers@lorenzinifoundation.org |
Branch
Office
Biomarkers 2005
Giovanni Lorenzini
Medical Foundation
6535 Fannin, M.S. A-601
Houston, Texas 77030-2704 (USA)
Phone: (+1) 713 7970401
Fax: (+1) 713 7968853
E-mail:
biomarkers@bcm.tmc.edu |
|
|
